European Patent Organisation

Kane Biotech Receives Decisions to Grant for Two European Patents Providing Broad Protection of coactiv+™ Technology for Wound Care, Skin Infections and Personal Care Formulations

Retrieved on: 
Thursday, July 29, 2021
Intellectual property law, Patent offices, International Searching and Preliminary Examining Authorities, European Patent Organisation, Patent examiner, Patent portfolio, European Patent Office

The allowed claims cover composition of matter for the company's proprietary formulations for use in treating wounds and skin infections and in personal care formulations.

Key Points: 
  • The allowed claims cover composition of matter for the company's proprietary formulations for use in treating wounds and skin infections and in personal care formulations.
  • A Decision to Grant is the European Examiners confirmation that the European Patent Office has decided to grant Kane the patent and has set the grant date.
  • "These patents are important additions to the existing portfolio covering Kanes coactiv+ technology platform," saidGordon Guay, the company's Chief Scientific Officer.
  • Its multi-functional and gentle formulation makes it a perfect companion treatment to DispersinB Hydrogel, also part of the Kane Biotech antibiofilm wound care portfolio.

GBT - 3D CHIP and MEMORY Patent Will Be Published in Europe

Retrieved on: 
Wednesday, July 21, 2021
Intellectual property law, Countries, Government, European Patent Organisation, International Searching and Preliminary Examining Authorities, Patent offices, Gazettes, Patent, European Patent Convention, United States Patent and Trademark Office, European Patent Bulletin

SAN DIEGO, July 21, 2021 (GLOBE NEWSWIRE) -- GBT   Technologies   Inc.   ( OTC PINK: GTCH ) ("GBT” or the “Company”), is pleased to report the upcoming publication of its 3D CHIP and MEMORY patent in Europe on July 28, 2021. The application has been allocated the number 19862631.9 and designates all European Patent Convention (“EPC”) states, as of the Patent Cooperation Treaty (“PCT”) filing date.

Key Points: 
  • SANDIEGO, July 21, 2021 (GLOBE NEWSWIRE) -- GBT Technologies Inc. ( OTC PINK: GTCH ) ("GBT or the Company), is pleased to report the upcoming publication of its3D CHIP and MEMORY patent in Europe on July 28, 2021.
  • The application has been allocated the number 19862631.9 and designates all European Patent Convention (EPC) states, as of the Patent Cooperation Treaty (PCT) filing date.
  • The companys 3D microchip patent was filed on March 5, 2019 and was granted as of December 1, 2020 by the United States Patent and Trademark Office (USPTO); U.S. Patent No.
  • The bibliographic data of the above-mentioned Euro-PCT application will be published on28.07.21 in Section 1.1 of the European Patent Bulletin.

TrippBio receives Notice of Allowance from the U.S. Patent Office for Therapeutic Treatment of COVID-19 Infections

Retrieved on: 
Thursday, July 15, 2021
Intellectual property law, Patent offices, International Searching and Preliminary Examining Authorities, Patent law, European Patent Organisation, United States Patent and Trademark Office, Patent application, Patent office, European Patent Office, Term of patent

JACKSONVILLE, Fla., July 15, 2021 /PRNewswire-PRWeb/ --TrippBio, Inc. (TrippBio), a clinical development-stage company developing antiviral treatments with an initial focus on COVID-19, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for patent application No.

Key Points: 
  • JACKSONVILLE, Fla., July 15, 2021 /PRNewswire-PRWeb/ --TrippBio, Inc. (TrippBio), a clinical development-stage company developing antiviral treatments with an initial focus on COVID-19, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for patent application No.
  • 16/875,487, and the European Patent Office (EPO) has issued a favorable opinion in a counterpart European application.
  • The availability of safe and effective treatment options can reduce the rate of hospitalizations and hopefully the long-term effects of COVID-19."
  • TrippBio is founded on the scientific research of Ralph Tripp, Ph.D., Georgia Research Alliance Chair and professor at the University of Georgia.

Optinose Technology Inventor Per Djupesland Named Winner of European Inventor Award 2021 for Industry

Retrieved on: 
Thursday, June 24, 2021
Intellectual property law, European Patent Organisation, Countries, Law, European Inventor Award, European Patent Office, Inventor, European Patent Convention

Per Djupesland received the European Inventor Award 2021 in the Industry category from the European Patent Office (EPO) for his invention of the technology that serves as a basis for the Optinose Exhalation Delivery System (EDS).

Key Points: 
  • Per Djupesland received the European Inventor Award 2021 in the Industry category from the European Patent Office (EPO) for his invention of the technology that serves as a basis for the Optinose Exhalation Delivery System (EDS).
  • On behalf of the team at Optinose I would like to congratulate our friend and colleague, Per Djupesland, for receiving this important recognition, said Peter Miller, CEO of Optinose.
  • The European Inventor Award was launched by the EPO in 2006.
  • The Award is conferred in five categories (Industry, Research, Small and Medium-sized Enterprises, Non-EPO countries and Lifetime achievement).

Two U.S. Researchers Win European Inventor Award 2021

Retrieved on: 
Thursday, June 17, 2021
Intellectual property law, European Patent Organisation, European Inventor Award, European Patent Office, Inventor

MUNICH, June 17, 2021 /PRNewswire/ --The European Patent Office (EPO) today honored two U.S. researchers with the European Inventor Award 2021.

Key Points: 
  • MUNICH, June 17, 2021 /PRNewswire/ --The European Patent Office (EPO) today honored two U.S. researchers with the European Inventor Award 2021.
  • Commenting on the Popular Prize, EPO President Antnio Campinos said: "This Award underlines how innovation touches the lives of people everywhere in the world.
  • The 2021 European Inventor Award ceremony was held digitally for the first time and was open to the public who tuned in to the event from around the world.
  • The Popular Prize is decided by the public, who select their favourite inventor from among the 15 finalists.

Immutep Secures Second European Patent For Eftilagimod Alpha, A Soluble LAG-3 Protein, In Combination With A PD-1 Pathway Inhibitor

Retrieved on: 
Wednesday, June 2, 2021
Countries, Law, Government, Patent law, Immutep, European Patent Organisation, Patent application, Divisional patent application, Patent, European Patent Convention

This European patent was filed as a divisional application and follows the grant of the European parent patent announced in November 2018, and the corresponding United States patents announced in December 2020 and March 2021.

Key Points: 
  • This European patent was filed as a divisional application and follows the grant of the European parent patent announced in November 2018, and the corresponding United States patents announced in December 2020 and March 2021.
  • The claims are also directed to related methods of use in the treatment of cancer.
  • It also highlights the critical investments we are making to protect efti which underpin further clinical development and commercialisation of this asset.
  • Immutep is listed on the Australian Securities Exchange (IMM), and on the NASDAQ (IMMP) in the United States.

European Inventor Award 2021: Meet some of today's most inspiring innovators at digital event on June 17 and vote online for your favorite inventor

Retrieved on: 
Tuesday, June 1, 2021
Intellectual property law, European Patent Organisation, Patent law, European Inventor Award, Inventors, European Patent Office, Invention

Watch the European Inventor Award ceremony online on Thursday, June 17, 2021 at 1:00 pm EDT (19:00 CEST)

Key Points: 
  • Watch the European Inventor Award ceremony online on Thursday, June 17, 2021 at 1:00 pm EDT (19:00 CEST)
    The public is invited to vote online for their favorite inventor to win the Popular Prize; poll open now at popular-prize.epo.org
    The European Patent Office (EPO) is hosting the first-ever digital edition of the European Inventor Award ceremony on Thursday,June 17, which viewers will be able to watch at inventoraward.org .
  • The 15 award finalists have made significant advances in fields rangingfrom diagnostics and ultrasound imaging to biometrics, sustainable plastic production and wildlife protection.
  • While the winners of the Award's five categories are selected by an independent international jury , it is the public alone that decides who receives the Popular Prize.
  • Votes can be cast anytime until June 17 at popular-prize.epo.org for inventors or teams of inventors from among this year's 15 finalists .

Rogers Announces Settlement of Patent Infringement Lawsuits Against KCC

Retrieved on: 
Wednesday, May 26, 2021
Technology, Mobile, Wireless, Semiconductor, Engineering, Chemicals, Plastics, Aerospace, Manufacturing, Software, Hardware, Patent infringement, Patent, European Patent Organisation

Rogers Corporation (NYSE:ROG) announced today that it has settled its patent infringement litigation initiated against KCC Corporation.

Key Points: 
  • Rogers Corporation (NYSE:ROG) announced today that it has settled its patent infringement litigation initiated against KCC Corporation.
  • Rogers (through its German subsidiary) filed patent infringement proceedings in Germany against KCC and its German subsidiary alleging infringement of certain Rogers patents relating to direct bonded copper (DBC) substrate materials.
  • The settlement resolves these proceedings, together with related patent actions.
  • Financial and other settlement terms were not disclosed, and neither party acknowledges infringement or non-infringement, or validity or invalidity, of the subject patents.

Patent for ColdZyme approved in Japan

Retrieved on: 
Friday, May 21, 2021
Intellectual property law, Countries, Government, European Patent Organisation, Patent law, Patent, European Patent Office, European Patent Convention, Term of patent, Outline of patents

b'STOCKHOLM, May 21, 2021 /PRNewswire/ -- The Japanese patent authority has granted Enzymatica\'s patent for the cod enzyme that is a key component of Enzymatica\'s cold spray ColdZyme for the Japanese market.

Key Points: 
  • b'STOCKHOLM, May 21, 2021 /PRNewswire/ -- The Japanese patent authority has granted Enzymatica\'s patent for the cod enzyme that is a key component of Enzymatica\'s cold spray ColdZyme for the Japanese market.
  • Corresponding patent was granted by the European Patent Office, EPO, in the spring of 2020.\nEnzymatica has developed an improved cod enzyme formulation for ColdZyme, for which new patent applications were globally filed in 2016.
  • The new patent prolongs the protection for ColdZyme and other Enzymatica products based on the same technology platform for another 15 years.
  • This is a major strengthening of the Enzymatica patent portfolio and represents a significant milestone for the continuous commercialization of the company\'s key products.\n"Having the new patent also granted in Japan, we will have another large market, besides Europe and Russia, that will provide ColdZyme with a long-term patent protection.

Six U.S. Researchers Named Finalists in European Inventor Award 2021

Retrieved on: 
Thursday, May 6, 2021
European Patent Organisation, Articles, European Inventor Award, Petri dish, Soil, Bacteria, Nature, Science and technology

However, Epstein and Lewis discovered the missing ingredient in conventional petri dishes: nutrients from the bacteria\'s native soil.

Key Points: 
  • However, Epstein and Lewis discovered the missing ingredient in conventional petri dishes: nutrients from the bacteria\'s native soil.
  • "The first question that an investor asks is what you own, and the only thing we owned was our IP.
  • This could help researchers find new antibiotics, tackle drug resistance and, ultimately save lives.
  • Their invention shows how innovation can help protect our privacy and security," said EPO President Antnio Campinos, announcing the European Inventor Award 2021 finalists.